Specific anti-beta tubulin antibodies in differential diagnosis of dementias;Specifické protilátky proti beta-tubulinu v diferenciální diagnostice demencí

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 70, Issue 2, 2007, Pages 152-157

  Škoda, David ^a   Hort, J ^a   Vyhnalek M ^a   Glosova L ^a   Minarikova M ^a   Jinoch, P ^b   Kranda, K ^c   Bojar, M ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b VIDIA sro ^*  (Czech Republic)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alzheimer's disease; Anti bctlll antibodies; Apoptosis; Frontotemporal lobar degeneration; Markers of dementia; Mixed dementia; Necrosis; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; BETA TUBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; LABORATORY DIAGNOSIS; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 53549095521     PISSN: 12107859     EISSN: 18024041     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hedden T, Gabrieli JDE Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain. Curr Opin Neurol 2005; 18: 740-7.
2. Glosová L, Hort J, Bojar M, Škoda D. Vyšetřování celkového tau proteinu, phospho-tau proteinu a beta-amyloidu v mozkomíšním moku - naše první zkušenosti. Klin Biochem Metab 2004; 12: 113-6.
3. Andreasen N, Sjogren M, Blennow K. CSF markers for Alzheimer's diseases: total tau, phospho-tau and Abeta42. World J Biol Psychiatry 2003; 4: 147-55.
4. Blennow K. Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 2004; 1: 213-25.
5. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005; 4: 771-80.
6. Sullivan KF, Cleveland DW. Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proc Natl Acad Sci USA 1986; 83; 4327-31.
7. Banerjee A, Roach MC, Trcka P, Luduena RF. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of betatubulin. J Biol Chem 1990; 265: 1794-9.
8. Stubbs EB Jr, Fisher MA, Siegel GJ. Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization. Acta Neuropathol (Berl) 1998; 95: 302-5.
9. Norgren N, Rosengren L, Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Research 2003; 987: 25-31.
10. Semra YK, Seidi OA, Sharief MK. Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability. J Neuroimmunol 2002; 122: 132-9.
11. Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology 2002; 58: 1372-81.
12. Dighiero G, Guilbert B, Avrameas S. Naturally occurring antibodies against nine common antigens in humans sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 1982; 128: 2788-92.
13. Avrameas S, Ternynck T. The natural autoantibodies system: between hypotheses and facts. Mol Immunol 1993; 30: 1133-42.
14. Terryberry JW, Thor G, Peter JB. Autoantibodies in neurodegenerative diseases: antigen specific frequencies and intrathecal analysis. Neurobiol Aging 1998; 19: 205-16.
15. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613-20.
16. Vyhnálek M, Škoda D, Varjassyová A, Hort J. Sémantická demence - důkaz mnohotvárnosti pamět'ových procesů. Neurol pro praxi 2005; 6: 330-332.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
18. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
19. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-S4.
20. Sjogren M, Blomberg M, Jonsson M, Wahlund LO, Edman A, Lind K et al. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res 2001; 66: 510-6.
21. Dráberová E, Lukáš Z, Ivanyi D, Viklický V, Dráber P. Expression of class III β-tubulin in normal and neoplastic human tissues. Histochem Cell Biol 1998; 109: 231-9.
22. Sjogren M, Wallin A. Pathophysiological aspects of frontotemporal dementia-emphasis on cytoskeleton proteins and autoimmunity Mech Ageing Dev 2001; 122: 1923-35.
23. Wallin A, Sjögren M. Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia. Mech Ageing Dev 2001; 122: 1937-49.
24. Rosengren LE, Karlsson JE, Sjogren M, Blennow K, Wallin A. Neurofilament protein levels in CSF are increased in dementia. Neurology 1999; 52: 1090-3.
25. Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Iqbal K et al. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 2002; 320: 156-60.
26. Prasannan L, Misek DE, Hinderer R, Michon J, Geiger JD, Hanash SM. Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma. Clin Cancer Res 2000; 6: 3949-56.
27. Stubbs EB Jr, Fisher MA, Wilson JR, Siegel GJ. High-titer immunogiobulin M antibody to nerve-specific class III beta-tubulin in the serum of a patient with sensory demyelinating polyneuropathy. Muscle Nerve 1996; 19: 1638-9.